Clinical heterogeneity of atypical fractures during prolonged use of bisphosphonates - Risk factors and bone turnover markers

被引:1
|
作者
Piazzetta, Giovana [1 ]
Baracho, Filipe R. [2 ]
de Oliveira, Larissa [1 ]
Santos, Gustavo R. [1 ]
Kulak, Carolina A. M. [1 ,3 ]
Borba, Victoria Z. C. [1 ,3 ]
机构
[1] UFPR, Hosp Clin, Dept Clin Med, Curitiba, PR, Brazil
[2] UFPR, Hosp Clin, Dept Ortopedia & Traumatol, Curitiba, PR, Brazil
[3] UFPR, Hosp Clin, SEMPR, Serv Endocrinol, Curitiba, PR, Brazil
关键词
FEMORAL FRACTURES; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; STRONTIUM RANELATE; OSTEOPOROSIS; MICROARCHITECTURE; ALENDRONATE; STRENGTH; THERAPY;
D O I
10.1590/0004-2730000003229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:855 / 861
页数:7
相关论文
共 37 条
  • [31] Changes in serum levels of biochemical markers of bone turnover during 10 years among Japanese men and women: associated factors and birth-cohort effect. The Taiji Study
    Yoshimura, Noriko
    Muraki, Shigeyuki
    Oka, Hiroyuki
    Kawaguchi, Hiroshi
    Nakamura, Kozo
    Akune, Toru
    JOURNAL OF BONE AND MINERAL METABOLISM, 2011, 29 (06) : 699 - 708
  • [32] High physical activity is associated with greater cortical bone size, better physical function, and with lower risk of incident fractures independently of clinical risk factors in older women from the SUPERB study
    Johansson, Lisa
    Litsne, Henrik
    Axelsson, Kristian F.
    Lorentzon, Mattias
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (09) : 1284 - 1295
  • [33] Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
    Miyauchi, Akimitsu
    Matsumoto, Toshio
    Sugimoto, Toshitsugu
    Tsujimoto, Mika
    Warner, Margaret R.
    Nakamura, Toshitaka
    BONE, 2010, 47 (03) : 493 - 502
  • [34] SERUM LEVELS OF BONE TURNOVER MARKERS, ESTABLISHING Z-SCORES FOR USE IN RESEARCH AND DAILY CLINICAL PRACTICE: DATA FROM A DUTCH HEALTHY REFERENCE COHORT
    Siderius, M.
    Arends, S.
    Kobold, A. Muller
    Wagenmakers, L.
    Koerts, K.
    Spoorenberg, A.
    Van der Veer, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 507 - 507
  • [35] Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study
    Takakuwa, Masayuki
    Iwamoto, Jun
    Konishi, Masahisa
    Zhou, Qi
    Itabashi, Koichi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2011, 29 (01) : 88 - 95
  • [36] Comment on Kanis et al.: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
    Moayyeri, A.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 591 - 592
  • [37] Comment on Kanis et al.: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
    A. Moayyeri
    Osteoporosis International, 2008, 19 : 591 - 592